What is the appropriate workup for inflammatory arthritis in a 34‑year‑old patient?

Workup for Inflammatory Arthritis in a 34-Year-Old

Begin with a focused history and physical examination, then immediately order ESR, CRP, rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), and baseline x-rays of hands, wrists, and feet—these core tests establish diagnosis and prognosis while guiding further evaluation. 1

Initial Clinical Assessment

Your history must capture specific inflammatory features:

• Morning stiffness duration (>30 minutes suggests inflammatory arthritis) 1
• Number and pattern of swollen/tender joints (small joint involvement and ≥3 joints increase likelihood of rheumatoid arthritis) 1
• Symptom duration (≥6 weeks predicts persistent disease) 1
• Functional impairment using standardized assessment 1
• Extra-articular manifestations (rash, oral ulcers, eye symptoms, entheseal pain) 1

Physical examination should document:

• Tender and swollen joint counts with specific attention to symmetry and small joint involvement 1
• Presence of true synovitis (warmth, swelling, effusion) versus bony hypertrophy 1
• Axial and entheseal involvement (suggests spondyloarthropathy) 1

Essential Laboratory Tests

Order these baseline tests for every patient:

Inflammatory Markers

• ESR and CRP at baseline—these have diagnostic value for RA and guide prognosis, though CRP alone is a poor predictor of persistence 1
• Repeat when clinically relevant during follow-up 1

Autoantibodies (Critical for Diagnosis and Prognosis)

• RF and ACPA—both strongly predict RA diagnosis and worse outcomes (erosions, persistent disease) 1
• Important caveat: Negative RF/ACPA does NOT exclude progression to RA 1
• If connective tissue disease suspected (based on extra-articular features), add ANA, anti-dsDNA, extractable nuclear antigens 1

Additional Baseline Labs

• Complete blood count 1
• Comprehensive metabolic panel (liver function, renal function, glucose, urate) 1
• Urinalysis 1

Conditional Testing

• HLA-B27 only if clinical features suggest spondyloarthropathy (axial symptoms, enthesitis, asymmetric oligoarthritis, inflammatory back pain) 1
• Microbiological assessment if infectious arthritis in differential 1

Imaging Studies

Baseline x-rays are mandatory:

• X-rays of hands, wrists, and feet at baseline—erosions predict RA development and persistent disease 1
• X-rays of other affected joints 1
• Repeat hand/wrist/foot x-rays within 1 year 1

Advanced imaging considerations:

• MRI of hands and wrists may be considered if RA is suspected but diagnosis uncertain—insufficient evidence for routine use 1
• Ultrasound can confirm clinical arthritis but not routinely recommended for diagnosis/prognosis 1
• Clinical examination remains the gold standard for detecting arthritis 2

Critical Pitfalls to Avoid

Do NOT order a broad "rheumatological panel"—this increases false positives and leads to unnecessary anxiety, further testing, and inappropriate treatment 3. Tailor investigations to your differential diagnosis based on pretest probability.

Do NOT rely on positive serology alone—RF and ACPA can be positive in healthy individuals; diagnosis requires compatible clinical presentation 3.

Do NOT routinely perform:

• Genetic testing beyond HLA-B27 in specific contexts 1
• Synovial biopsy (reserve for persistent monoarthritis when diagnosis unclear) 1

Risk Stratification for Persistent Disease

Document these predictors of chronicity and erosive disease 1:

• Disease duration ≥6 weeks
• Morning stiffness >30 minutes
• Functional impairment
• Small joint involvement
• Knee involvement
• ≥3 joints involved
• RF or ACPA positivity
• Radiographic erosions

Patients with multiple risk factors require early DMARD therapy (ideally within 3 months), even without meeting classification criteria 2.

Differential Diagnosis Framework

Consider all causes systematically 1:

• Autoimmune: RA, spondyloarthropathies, connective tissue diseases
• Infectious: viral, bacterial (including reactive arthritis)
• Crystal-induced: gout, pseudogout
• Degenerative: osteoarthritis (though less likely at age 34)
• Malignancy-associated
• Metabolic

The 34-year-old age makes RA and spondyloarthropathies most likely if truly inflammatory, though viral arthritis and reactive arthritis remain important considerations.

Timing and Referral

Refer to rheumatology within 6 weeks of symptom onset 2—early specialist evaluation improves outcomes including joint damage and physical function.